<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HB3794</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HB3794 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="number"></td><td class="junk"></td><td class="xsl"><table class="xsl" width="100%"><tr><td class="xsl"><center><b><pre><font size="3" face="Courier New">104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026</font><br>HB3794</pre></b></center><p> </p>Introduced 2/18/2025, by Rep. Ryan Spain<p> </p><b>SYNOPSIS AS INTRODUCED:</b><br> </td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><table class="xsl" width="100%"><colgroup width="50%"></colgroup><colgroup width="50%"></colgroup><tr><td class="synopsis"><code>5 ILCS 140/7.5</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>215 ILCS 5/513b1</code></td><td class="synopsis"></td></tr><tr><td class="synopsis"><code>225 ILCS 85/19.5</code></td><td class="synopsis"></td></tr></table><p></p></td></tr><tr><td class="xsl"><code>    </code><code>Amends the Pharmacy Benefit Manager Article of the Illinois Insurance </code><code>Code. Provides that a covered individual's defined cost sharing for each </code><code>prescription drug shall be calculated at the point of sale based on a price </code><code>that is reduced by an amount equal to at least 80% of all rebates received, </code><code>or to be received, or to be received, in connection with the dispensing or </code><code>administration of the prescription drug. Provides that a health insurer or </code><code>its agents shall not publish or otherwise reveal information regarding the </code><code>actual amount of rebates a health insurer receives on a product or </code><code>therapeutic class of products, manufacturer-specific basis, or </code><code>pharmacy-specific basis and that the information is confidential. Defines </code><code>terms. Amends the Freedom of Information Act to make a conforming change. </code><code>Amends the Pharmacy Practice Act. Provides that a pharmacist may </code><code>substitute a biological product (instead of an interchangeable biological </code><code>product) if, among other requirements, the product being considered for </code><code>substitution is either the reference product or a product approved by the </code><code>United States Food and Drug Administration as a biosimilar of the </code><code>prescribed biological product (instead of if the substituted product has </code><code>been determined by the United States Food and Drug Administration to be </code><code>interchangeable with the prescribed biological product). Makes conforming </code><code>changes. </code></td></tr><tr align="right" class="lineNum"><td class="xsl"><br><br></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left"></td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><p> </p><p> </p><center><b>A BILL FOR</b></center><p></p></td></tr></table><p> </p></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AN ACT concerning prescription drugs.</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>The Freedom of Information Act is amended by </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>changing Section 7.5 as follows:</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(5 ILCS 140/7.5)</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 7.5. </code><code>Statutory exemptions. </code><code>To the extent provided for </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>by the statutes referenced below, the following shall be </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>exempt from inspection and copying:</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(a) All information determined to be confidential </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>under Section 4002 of the Technology Advancement and </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Development Act.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(b) Library circulation and order records identifying </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>library users with specific materials under the Library </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>Records Confidentiality Act.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(c) Applications, related documents, and medical </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>records received by the Experimental Organ Transplantation </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>Procedures Board and any and all documents or other </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>records prepared by the Experimental Organ Transplantation </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>Procedures Board or its staff relating to applications it </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>has received.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(d) Information and records held by the Department of </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>Public Health and its authorized representatives relating </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>to known or suspected cases of sexually transmitted </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>infection or any information the disclosure of which is </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>restricted under the Illinois Sexually Transmitted </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>Infection Control Act.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(e) Information the disclosure of which is exempted </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>under Section 30 of the Radon Industry Licensing Act.</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(f) Firm performance evaluations under Section 55 of </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>the Architectural, Engineering, and Land Surveying </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>Qualifications Based Selection Act.</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(g) Information the disclosure of which is restricted </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>and exempted under Section 50 of the Illinois Prepaid </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Tuition Act.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(h) Information the disclosure of which is exempted </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>under the State Officials and Employees Ethics Act, and </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>records of any lawfully created State or local inspector </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>general's office that would be exempt if created or </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>obtained by an Executive Inspector General's office under </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>that Act.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(i) Information contained in a local emergency energy </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>plan submitted to a municipality in accordance with a </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>local emergency energy plan ordinance that is adopted </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>under Section 11-21.5-5 of the Illinois Municipal Code.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(j) Information and data concerning the distribution </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>of surcharge moneys collected and remitted by carriers </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>under the Emergency Telephone System Act.</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(k) Law enforcement officer identification information </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>or driver identification information compiled by a law </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>enforcement agency or the Department of Transportation </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>under Section 11-212 of the Illinois Vehicle Code.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(l) Records and information provided to a residential </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>health care facility resident sexual assault and death </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>review team or the Executive Council under the Abuse </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Prevention Review Team Act.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(m) Information provided to the predatory lending </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>database created pursuant to Article 3 of the Residential </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>Real Property Disclosure Act, except to the extent </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>authorized under that Article.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(n) Defense budgets and petitions for certification of </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>compensation and expenses for court appointed trial </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>counsel as provided under Sections 10 and 15 of the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>Capital Crimes Litigation Act (repealed). This subsection </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>(n) shall apply until the conclusion of the trial of the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>case, even if the prosecution chooses not to pursue the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>death penalty prior to trial or sentencing.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(o) Information that is prohibited from being </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>disclosed under Section 4 of the Illinois Health and </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>Hazardous Substances Registry Act.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(p) Security portions of system safety program plans, </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>investigation reports, surveys, schedules, lists, data, or </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>information compiled, collected, or prepared by or for the </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>Department of Transportation under Sections 2705-300 and </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>2705-616 of the Department of Transportation Law of the </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>Civil Administrative Code of Illinois, the Regional </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>Transportation Authority under Section 2.11 of the </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>Regional Transportation Authority Act, or the St. Clair </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>County Transit District under the Bi-State Transit Safety </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>Act (repealed). </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(q) Information prohibited from being disclosed by the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Personnel Record Review Act. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(r) Information prohibited from being disclosed by the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>Illinois School Student Records Act. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(s) Information the disclosure of which is restricted </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>under Section 5-108 of the Public Utilities Act. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(t) (Blank). </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(u) Records and information provided to an independent </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>team of experts under the Developmental Disability and </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>Mental Health Safety Act (also known as Brian's Law). </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(v) Names and information of people who have applied </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>for or received Firearm Owner's Identification Cards under </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>the Firearm Owners Identification Card Act or applied for </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>or received a concealed carry license under the Firearm </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>Concealed Carry Act, unless otherwise authorized by the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>Firearm Concealed Carry Act; and databases under the </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>Firearm Concealed Carry Act, records of the Concealed </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>Carry Licensing Review Board under the Firearm Concealed </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>Carry Act, and law enforcement agency objections under the </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>Firearm Concealed Carry Act. </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(v-5) Records of the Firearm Owner's Identification </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>Card Review Board that are exempted from disclosure under </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>Section 10 of the Firearm Owners Identification Card Act.</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(w) Personally identifiable information which is </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>exempted from disclosure under subsection (g) of Section </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>19.1 of the Toll Highway Act.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(x) Information which is exempted from disclosure </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>under Section 5-1014.3 of the Counties Code or Section </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>8-11-21 of the Illinois Municipal Code. </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(y) Confidential information under the Adult </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>Protective Services Act and its predecessor enabling </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>statute, the Elder Abuse and Neglect Act, including </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>information about the identity and administrative finding </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>against any caregiver of a verified and substantiated </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>decision of abuse, neglect, or financial exploitation of </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>an eligible adult maintained in the Registry established </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>under Section 7.5 of the Adult Protective Services Act. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(z) Records and information provided to a fatality </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>review team or the Illinois Fatality Review Team Advisory </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>Council under Section 15 of the Adult Protective Services </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(aa) Information which is exempted from disclosure </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>under Section 2.37 of the Wildlife Code. </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(bb) Information which is or was prohibited from </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>disclosure by the Juvenile Court Act of 1987. </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(cc) Recordings made under the Law Enforcement </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>Officer-Worn Body Camera Act, except to the extent </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>authorized under that Act.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(dd) Information that is prohibited from being </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>disclosed under Section 45 of the Condominium and Common </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>Interest Community Ombudsperson Act. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ee) Information that is exempted from disclosure </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>under Section 30.1 of the Pharmacy Practice Act. </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ff) Information that is exempted from disclosure </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>under the Revised Uniform Unclaimed Property Act. </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(gg) Information that is prohibited from being </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>disclosed under Section 7-603.5 of the Illinois Vehicle </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>Code. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(hh) Records that are exempt from disclosure under </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>Section 1A-16.7 of the Election Code. </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ii) Information which is exempted from disclosure </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>under Section 2505-800 of the Department of Revenue Law of </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>the Civil Administrative Code of Illinois. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(jj) Information and reports that are required to be </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>submitted to the Department of Labor by registering day </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>and temporary labor service agencies but are exempt from </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>disclosure under subsection (a-1) of Section 45 of the Day </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>and Temporary Labor Services Act. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(kk) Information prohibited from disclosure under the </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>Seizure and Forfeiture Reporting Act. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ll) Information the disclosure of which is restricted </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>and exempted under Section 5-30.8 of the Illinois Public </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>Aid Code. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 7 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(mm) Records that are exempt from disclosure under </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>Section 4.2 of the Crime Victims Compensation Act. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(nn) Information that is exempt from disclosure under </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>Section 70 of the Higher Education Student Assistance Act. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(oo) Communications, notes, records, and reports </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>arising out of a peer support counseling session </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>prohibited from disclosure under the First Responders </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>Suicide Prevention Act. </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(pp) Names and all identifying information relating to </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>an employee of an emergency services provider or law </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>enforcement agency under the First Responders Suicide </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Prevention Act. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(qq) Information and records held by the Department of </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>Public Health and its authorized representatives collected </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>under the Reproductive Health Act. </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(rr) Information that is exempt from disclosure under </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>the Cannabis Regulation and Tax Act. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ss) Data reported by an employer to the Department of </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>Human Rights pursuant to Section 2-108 of the Illinois </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>Human Rights Act.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(tt) Recordings made under the Children's Advocacy </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>Center Act, except to the extent authorized under that </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(uu) Information that is exempt from disclosure under </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>Section 50 of the Sexual Assault Evidence Submission Act. </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(vv) Information that is exempt from disclosure under </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 8 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>subsections (f) and (j) of Section 5-36 of the Illinois </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>Public Aid Code. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ww) Information that is exempt from disclosure under </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>Section 16.8 of the State Treasurer Act. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(xx) Information that is exempt from disclosure or </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>information that shall not be made public under the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Illinois Insurance Code. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(yy) Information prohibited from being disclosed under </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>the Illinois Educational Labor Relations Act.</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(zz) Information prohibited from being disclosed under </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>the Illinois Public Labor Relations Act. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(aaa) Information prohibited from being disclosed </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>under Section 1-167 of the Illinois Pension Code. </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(bbb) Information that is prohibited from disclosure </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>by the Illinois Police Training Act and the Illinois State </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>Police Act. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ccc) Records exempt from disclosure under Section </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>2605-304 of the Illinois State Police Law of the Civil </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>Administrative Code of Illinois. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ddd) Information prohibited from being disclosed </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>under Section 35 of the Address Confidentiality for </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>Victims of Domestic Violence, Sexual Assault, Human </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>Trafficking, or Stalking Act. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(eee) Information prohibited from being disclosed </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>under subsection (b) of Section 75 of the Domestic </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>Violence Fatality Review Act. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 9 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(fff) Images from cameras under the Expressway Camera </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>Act. This subsection (fff) is inoperative on and after </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>July 1, 2025. </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(ggg) Information prohibited from disclosure under </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>paragraph (3) of subsection (a) of Section 14 of the Nurse </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>Agency Licensing Act. </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(hhh) Information submitted to the Illinois State </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>Police in an affidavit or application for an assault </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>weapon endorsement, assault weapon attachment endorsement, </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>.50 caliber rifle endorsement, or .50 caliber cartridge </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>endorsement under the Firearm Owners Identification Card </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(iii) Data exempt from disclosure under Section 50 of </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>the School Safety Drill Act. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(jjj) Information exempt from disclosure under Section </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>30 of the Insurance Data Security Law. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(kkk) Confidential business information prohibited </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>from disclosure under Section 45 of the Paint Stewardship </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(lll) Data exempt from disclosure under Section </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>2-3.196 of the School Code. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(mmm) Information prohibited from being disclosed </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>under subsection (e) of Section 1-129 of the Illinois </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>Power Agency Act. </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(nnn) Materials received by the Department of Commerce </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>and Economic Opportunity that are confidential under the </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 10 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>Music and Musicians Tax Credit and Jobs Act. </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(ooo)</code></u><code> </code><strike><code>(nnn)</code></strike><code> Data or information provided pursuant to </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>Section 20 of the Statewide Recycling Needs and Assessment </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(ppp)</code></u><code> </code><strike><code>(nnn)</code></strike><code> Information that is exempt from disclosure </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>under Section 28-11 of the Lawful Health Care Activity </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>Act. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(qqq)</code></u><code> </code><strike><code>(nnn)</code></strike><code> Information that is exempt from disclosure </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>under Section 7-101 of the Illinois Human Rights Act. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(rrr)</code></u><code> </code><strike><code>(mmm)</code></strike><code> Information prohibited from being </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>disclosed under Section 4-2 of the Uniform Money </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Transmission Modernization Act. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(sss)</code></u><code> </code><strike><code>(nnn)</code></strike><code> Information exempt from disclosure under </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>Section 40 of the Student-Athlete Endorsement Rights Act.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(ttt) Information prohibited from being disclosed </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <u><code>under subsection (g-5) of Section 513b1 of the Illinois </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <u><code>Insurance Code.</code></u><code> </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-36, eff. 6-25-21; 102-237, eff. 1-1-22; </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>102-292, eff. 1-1-22; 102-520, eff. 8-20-21; 102-559, eff. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>8-20-21; 102-813, eff. 5-13-22; 102-946, eff. 7-1-22; </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>102-1042, eff. 6-3-22; 102-1116, eff. 1-10-23; 103-8, eff. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>6-7-23; 103-34, eff. 6-9-23; 103-142, eff. 1-1-24; 103-372, </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>eff. 1-1-24; 103-472, eff. 8-1-24; 103-508, eff. 8-4-23; </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>103-580, eff. 12-8-23; 103-592, eff. 6-7-24; 103-605, eff. </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>7-1-24; 103-636, eff. 7-1-24; 103-724, eff. 1-1-25; 103-786, </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>eff. 8-7-24; 103-859, eff. 8-9-24; 103-991, eff. 8-9-24; </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 11 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>103-1049, eff. 8-9-24; revised 11-26-24.)</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 10. </code><code>The Illinois Insurance Code is amended by </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>changing Section 513b1 as follows:</code><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(215 ILCS 5/513b1)</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 513b1. </code><code>Pharmacy benefit manager contracts.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) As used in this Section: </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B drug discount program" means the program established </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>under Section 340B of the federal Public Health Service Act, </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>42 U.S.C. 256b. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B entity" means a covered entity as defined in 42 </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>U.S.C. 256b(a)(4) authorized to participate in the 340B drug </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>discount program. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B pharmacy" means any pharmacy used to dispense 340B </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>drugs for a covered entity, whether entity-owned or external. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Biological product" has the meaning ascribed to that term </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>in Section 19.5 of the Pharmacy Practice Act.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"Defined cost sharing" means a deductible payment or </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><u><code>coinsurance amount imposed on an enrollee for a covered </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>prescription drug under the enrollee's health benefit plan.</code></u><code> </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Maximum allowable cost" means the maximum amount that a </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>pharmacy benefit manager will reimburse a pharmacy for the </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>cost of a drug. </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Maximum allowable cost list" means a list of drugs for </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>which a maximum allowable cost has been established by a </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 12 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>pharmacy benefit manager. </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Pharmacy benefit manager" means a person, business, or </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>entity, including a wholly or partially owned or controlled </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>subsidiary of a pharmacy benefit manager, that provides claims </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>processing services or other prescription drug or device </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>services, or both, for health benefit plans. </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"Price protection rebate" means a negotiated price </code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><u><code>concession that accrues directly or indirectly to a health </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><u><code>insurer, or other party on behalf of the health insurer, if </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>there is an increase in the wholesale acquisition cost of a </code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><u><code>prescription drug above a specified threshold.</code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"Rebate" means:</code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(1) a negotiated price concession, including, without </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <u><code>limitation, base price concessions, whether described as a </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <u><code>rebate or not, reasonable estimates of any price </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <u><code>protection rebates, or performance-based price concessions </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <u><code>that may accrue, directly or indirectly, to the health </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <u><code>insurer during the coverage year from a manufacturer or </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <u><code>other party in connection with the dispensing or </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <u><code>administration of a prescription drug; or</code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(2) any reasonable estimate of a negotiated price </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <u><code>concession, fee, or other administrative cost that is </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <u><code>passed through, or is reasonably anticipated to be passed </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <u><code>through, to the health insurer and serves to reduce the </code></u></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <u><code>health insurer's liabilities for a prescription drug.</code></u><code> </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Retail price" means the price an individual without </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 13 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>prescription drug coverage would pay at a retail pharmacy, not </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>including a pharmacist dispensing fee. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Third-party payer" means any entity that pays for </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>prescription drugs on behalf of a patient other than a health </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>care provider or sponsor of a plan subject to regulation under </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>Medicare Part D, 42 U.S.C. 1395w-101 et seq. </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) A contract between a health insurer and a pharmacy </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>benefit manager must require that the pharmacy benefit </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>manager: </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) Update maximum allowable cost pricing information </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>at least every 7 calendar days. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) Maintain a process that will, in a timely manner, </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>eliminate drugs from maximum allowable cost lists or </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>modify drug prices to remain consistent with changes in </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>pricing data used in formulating maximum allowable cost </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>prices and product availability. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) Provide access to its maximum allowable cost list </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>to each pharmacy or pharmacy services administrative </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>organization subject to the maximum allowable cost list. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>Access may include a real-time pharmacy website portal to </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>be able to view the maximum allowable cost list. As used in </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>this Section, "pharmacy services administrative </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>organization" means an entity operating within the State </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>that contracts with independent pharmacies to conduct </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>business on their behalf with third-party payers. A </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>pharmacy services administrative organization may provide </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 14 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>administrative services to pharmacies and negotiate and </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>enter into contracts with third-party payers or pharmacy </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>benefit managers on behalf of pharmacies. </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) Provide a process by which a contracted pharmacy </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>can appeal the provider's reimbursement for a drug subject </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>to maximum allowable cost pricing. The appeals process </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>must, at a minimum, include the following: </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(A) A requirement that a contracted pharmacy has </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >        <code>14 calendar days after the applicable fill date to </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >        <code>appeal a maximum allowable cost if the reimbursement </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >        <code>for the drug is less than the net amount that the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >        <code>network provider paid to the supplier of the drug. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B) A requirement that a pharmacy benefit manager </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >        <code>must respond to a challenge within 14 calendar days of </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >        <code>the contracted pharmacy making the claim for which the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >        <code>appeal has been submitted.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(C) A telephone number and e-mail address or </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >        <code>website to network providers, at which the provider </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >        <code>can contact the pharmacy benefit manager to process </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >        <code>and submit an appeal.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(D) A requirement that, if an appeal is denied, </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >        <code>the pharmacy benefit manager must provide the reason </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >        <code>for the denial and the name and the national drug code </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >        <code>number from national or regional wholesalers.</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(E) A requirement that, if an appeal is sustained, </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >        <code>the pharmacy benefit manager must make an adjustment </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 15 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >        <code>in the drug price effective the date the challenge is </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >        <code>resolved and make the adjustment applicable to all </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >        <code>similarly situated network pharmacy providers, as </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >        <code>determined by the managed care organization or </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >        <code>pharmacy benefit manager. </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) Allow a plan sponsor contracting with a pharmacy </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>benefit manager an annual right to audit compliance with </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>the terms of the contract by the pharmacy benefit manager, </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>including, but not limited to, full disclosure of any and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>all rebate amounts secured, whether product specific or </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>generalized rebates, that were provided to the pharmacy </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>benefit manager by a pharmaceutical manufacturer.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) Allow a plan sponsor contracting with a pharmacy </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>benefit manager to request that the pharmacy benefit </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>manager disclose the actual amounts paid by the pharmacy </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>benefit manager to the pharmacy.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) Provide notice to the party contracting with the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>pharmacy benefit manager of any consideration that the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>pharmacy benefit manager receives from the manufacturer </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>for dispense as written prescriptions once a generic or </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>biologically similar product becomes available. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) In order to place a particular prescription drug on a </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>maximum allowable cost list, the pharmacy benefit manager </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>must, at a minimum, ensure that: </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) if the drug is a generically equivalent drug, it </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>is listed as therapeutically equivalent and </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 16 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>pharmaceutically equivalent "A" or "B" rated in the United </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>States Food and Drug Administration's most recent version </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>of the "Orange Book" or have an NR or NA rating by </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>Medi-Span, Gold Standard, or a similar rating by a </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>nationally recognized reference; </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the drug is available for purchase by each </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>pharmacy in the State from national or regional </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>wholesalers operating in Illinois; and </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) the drug is not obsolete. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) A pharmacy benefit manager is prohibited from limiting </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>a pharmacist's ability to disclose whether the cost-sharing </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>obligation exceeds the retail price for a covered prescription </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>drug, and the availability of a more affordable alternative </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>drug, if one is available in accordance with Section 42 of the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>Pharmacy Practice Act. </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) A health insurer or pharmacy benefit manager shall not </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>require an insured to make a payment for a prescription drug at </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>the point of sale in an amount that exceeds the lesser of: </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) the applicable cost-sharing amount; or</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the retail price of the drug in the absence of </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>prescription drug coverage. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) Unless required by law, a contract between a pharmacy </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>benefit manager or third-party payer and a 340B entity or 340B </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>pharmacy shall not contain any provision that: </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) distinguishes between drugs purchased through the </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>340B drug discount program and other drugs when </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 17 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>determining reimbursement or reimbursement methodologies, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>or contains otherwise less favorable payment terms or </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>reimbursement methodologies for 340B entities or 340B </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>pharmacies when compared to similarly situated non-340B </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>entities; </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) imposes any fee, chargeback, or rate adjustment </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>that is not similarly imposed on similarly situated </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>pharmacies that are not 340B entities or 340B pharmacies; </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) imposes any fee, chargeback, or rate adjustment </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>that exceeds the fee, chargeback, or rate adjustment that </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>is not similarly imposed on similarly situated pharmacies </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>that are not 340B entities or 340B pharmacies; </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) prevents or interferes with an individual's choice </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>to receive a covered prescription drug from a 340B entity </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>or 340B pharmacy through any legally permissible means, </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>except that nothing in this paragraph shall prohibit the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>establishment of differing copayments or other </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>cost-sharing amounts within the benefit plan for covered </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>persons who acquire covered prescription drugs from a </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>nonpreferred or nonparticipating provider; </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) excludes a 340B entity or 340B pharmacy from a </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>pharmacy network on any basis that includes consideration </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>of whether the 340B entity or 340B pharmacy participates </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>in the 340B drug discount program; </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) prevents a 340B entity or 340B pharmacy from using </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>a drug purchased under the 340B drug discount program; or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 18 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) any other provision that discriminates against a </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>340B entity or 340B pharmacy by treating the 340B entity </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>or 340B pharmacy differently than non-340B entities or </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>non-340B pharmacies for any reason relating to the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>entity's participation in the 340B drug discount program.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code> </code><u><code>(g-5) A covered individual's defined cost sharing for </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><u><code>each prescription drug shall be calculated at the point of </code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><u><code>sale based on a price that is reduced by an amount equal to at </code></u></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><u><code>least 80% of all rebates received or to be received in </code></u></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><u><code>connection with the dispensing or administration of the </code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><u><code>prescription drug.</code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>In complying with this Section, a health insurer or its </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>agents shall not publish or otherwise reveal information </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><u><code>regarding the actual amount of rebates a health insurer </code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><u><code>receives on a product or therapeutic class of products, </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><u><code>manufacturer-specific basis, or pharmacy-specific basis. The </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><u><code>information described in this subsection is: (i) considered </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><u><code>protected as a trade secret; (ii) considered proprietary and </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><u><code>confidential; (iii) not subject to disclosure under the </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><u><code>federal Freedom of Information Act or the Freedom of </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><u><code>Information Act; and (iv) not to be disclosed directly, </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><u><code>indirectly, or in a manner that would either allow for the </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>identification of an individual product, therapeutic class of </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><u><code>products, or manufacturer or have the potential to compromise </code></u></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><u><code>the financial, competitive, or proprietary nature of the </code></u></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><u><code>information. A health insurer shall impose the confidentiality </code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 19 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><u><code>protections of this subsection on any vendor or other third </code></u></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><u><code>party that performs health care or administrative services on </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><u><code>behalf of the health insurer that may receive or have access to </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><u><code>rebate information.</code></u><code> </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>Nothing in this subsection precludes a pharmacy benefit </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><u><code>manager or insurer from reducing an insured's cost sharing by </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><u><code>an amount greater than that required under this subsection.</code></u></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>As used in this subsection, "pharmacy benefit manager" and </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>"third-party payer" do not include pharmacy benefit managers </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>and third-party payers acting on behalf of a Medicaid program. </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(g) A violation of this Section by a pharmacy benefit </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>manager constitutes an unfair or deceptive act or practice in </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>the business of insurance under Section 424. </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(h) A provision that violates subsection (f) in a contract </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>between a pharmacy benefit manager or a third-party payer and </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>a 340B entity that is entered into, amended, or renewed after </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>July 1, 2022 shall be void and unenforceable. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(i)(1) A pharmacy benefit manager may not retaliate </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>against a pharmacist or pharmacy for disclosing information in </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>a court, in an administrative hearing, before a legislative </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>commission or committee, or in any other proceeding, if the </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>pharmacist or pharmacy has reasonable cause to believe that </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>the disclosed information is evidence of a violation of a </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>State or federal law, rule, or regulation.</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(2) A pharmacy benefit manager may not retaliate against a </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>pharmacist or pharmacy for disclosing information to a </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 20 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>government or law enforcement agency, if the pharmacist or </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>pharmacy has reasonable cause to believe that the disclosed </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>information is evidence of a violation of a State or federal </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>law, rule, or regulation.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(3) A pharmacist or pharmacy shall make commercially </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>reasonable efforts to limit the disclosure of confidential and </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>proprietary information.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(4) Retaliatory actions against a pharmacy or pharmacist </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>include cancellation of, restriction of, or refusal to renew </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>or offer a contract to a pharmacy solely because the pharmacy </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>or pharmacist has:</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(A) made disclosures of information that the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>pharmacist or pharmacy has reasonable cause to believe is </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>evidence of a violation of a State or federal law, rule, or </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>regulation;</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(B) filed complaints with the plan or pharmacy benefit </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>manager; or</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(C) filed complaints against the plan or pharmacy </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>benefit manager with the Department.</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(j) This Section applies to contracts entered into or </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>renewed on or after July 1, 2022</code><u><code>, except that subsection (g-5) </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><u><code>applies to contracts entered into or renewed on or after </code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><u><code>January 1, 2026</code></u><code>. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(k) This Section applies to any group or individual policy </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>of accident and health insurance or managed care plan that </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>provides coverage for prescription drugs and that is amended, </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 21 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>delivered, issued, or renewed on or after July 1, 2020. </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-778, eff. 7-1-22; 103-154, eff. 6-30-23; </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>103-453, eff. 8-4-23.)</code><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 15. </code><code>The Pharmacy Practice Act is amended by </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>changing Section 19.5 as follows:</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(225 ILCS 85/19.5)</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(Section scheduled to be repealed on January 1, 2028)</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 19.5. </code><code>Biological products.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) For the purposes of this Section:</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Biological product" has the meaning given to that term in </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>42 U.S.C. 262.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><strike><code>"Interchangeable biological product" means a biological </code></strike></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><strike><code>product that the United States Food and Drug Administration:</code></strike></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><strike><code>(1) has (A) licensed and (B) determined it to meet the </code></strike></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <strike><code>standards for interchangeability pursuant to 42 U.S.C. </code></strike></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <strike><code>262(k)(4); or</code></strike><code> </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><strike><code>(2) has determined is therapeutically equivalent as </code></strike></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <strike><code>set forth in the latest edition of or supplement to the </code></strike></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <strike><code>United States Food and Drug Administration's Approved Drug </code></strike></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <strike><code>Products with Therapeutic Equivalence Evaluations (Orange </code></strike></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <strike><code>Book).</code></strike></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) A pharmacist may substitute </code><u><code>a</code></u><code> </code><strike><code>an interchangeable</code></strike><code> </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>biological product for a prescribed biological product only if </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>all of the following conditions in this subsection (b) are </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 22 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>met:</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) </code><u><code>the product being considered for substitution is </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <u><code>either the reference product or a product approved by the </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <u><code>United States Food and Drug Administration as a biosimilar </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <u><code>of the prescribed biological product;</code></u><code> </code><strike><code>the substituted </code></strike></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <strike><code>product has been determined by the United States Food and </code></strike></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <strike><code>Drug Administration to be interchangeable, as defined in </code></strike></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <strike><code>subsection (a) of this Section, with the prescribed </code></strike></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <strike><code>biological product;</code></strike></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the prescribing physician does not designate </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>orally, in writing, or electronically that substitution is </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>prohibited in a manner consistent with Section 25 of this </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>Act; and</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) the pharmacy informs the patient of the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>substitution.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) Within 5 business days following the dispensing of a </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>biological product, the dispensing pharmacist or the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>pharmacist's designee shall make an entry of the specific </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>product provided to the patient, including the name of the </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>product and the manufacturer. The communication shall be </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>conveyed by making an entry that can be electronically </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>accessed by the prescriber through:</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) an interoperable electronic medical records </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>system;</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) an electronic prescribing technology;</code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) a pharmacy benefit management system; or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB3794</td><td class="xsl" align="center">- 23 -</td><td class="xsl" align="right">LRB104 10437 BAB 20512 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) a pharmacy record. </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Entry into an electronic records system as described in </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>this subsection (c) is presumed to provide notice in </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>accordance with this subsection (c). Otherwise, the pharmacist </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>shall communicate the biological product dispensed to the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>prescriber using facsimile, telephone, electronic </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>transmission, or other prevailing means, except that </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>communication shall not be required </code><u><code>if</code></u><code> </code><strike><code>where: (A) there is no </code></strike></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><strike><code>United States Food and Drug Administration-approved </code></strike></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><strike><code>interchangeable biological product for the product prescribed; </code></strike></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><strike><code>or (B)</code></strike><code> a refill prescription is not changed from the product </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>dispensed on the prior filling of the prescription. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) The pharmacy shall retain a record of the biological </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>product dispensed for a period of 5 years.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) </code><u><code>(Blank).</code></u><code> </code><strike><code>The Department shall maintain a link on its </code></strike></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><strike><code>Internet website to the current list of all biological </code></strike></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><strike><code>products determined by the United States Food and Drug </code></strike></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><strike><code>Administration to be interchangeable with a specific </code></strike></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><strike><code>biological product.</code></strike></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) The Department may adopt rules for compliance with </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>this Section.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-200, eff. 1-1-16</code><code>.)</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
